TFA
NVO

Toth Financial Advisory’s Novo Nordisk NVO Stock Holding History

Toth Financial Advisory’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$1.31K – 737
2024
Q3 		$1.31K Hold
11
– – ﹤0.01% 652
2024
Q2 		$1.57K Hold
11
– – ﹤0.01% 637
2024
Q1 		$1.41K Buy
+11
New +$1.31K ﹤0.01% 652
2020
Q3 		– Sell
-8,000
Closed -$262K – 588
2020
Q2 		$262K Buy
+8,000
New +$255K 0.06% 158

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Toth Financial Advisory's NVO Position: Q4 2024 in Review

Toth Financial Advisory sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 11 shares — an estimated $1.31K sold.

Toth Financial Advisory first reported a position in NVO in Q2 2020 and held it in 4 quarters. The position peaked at $262K in Q2 2020. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Toth Financial Advisory reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Toth Financial Advisory sold 11 Novo Nordisk shares in Q4 2024, an estimated $1.31K.
  • Toth Financial Advisory first reported a position in Novo Nordisk in Q2 2020 and held it in 4 quarters.
  • Toth Financial Advisory's Novo Nordisk position peaked at $262K in Q2 2020.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Toth Financial Advisory's 13F filing for Q4 2024, filed 21 Jan 2025.